oral pan-class IA PI3K inhibitor

Ph. I in advanced solid tumors

opt. from previous clinical candidat

J. Med. Chem

Novartis (NIBR), Basel, CH

NVP-CLR457 Chemical Structure, oral pan-class IA PI3K inhibitor - Novartis (NIBR), Basel, CH

Context. NVP-CLR457 (Novartis Institutes for BioMedical Research) is an oral, non-CNS-penetrating pan-class IA phosphoinositide 3-kinase (PI3K) inhibitor. Due to the key involvement of PI3K in the famed PI3K-Akt‚ąímTOR pathway,…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: